This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2018.
Company Filing History:
1 out of 834,453 Years Active: 2018
Title: Walton Ross: Innovator in Rhinovirus Research
Introduction
Walton Ross is a notable inventor based in Stratford upon Avon, Warwickshire, GB. He has made significant contributions to the field of immunology, particularly in the development of innovative approaches to combat rhinovirus infections. His work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Walton Ross holds a patent titled "Induction of cross-reactive cellular response against rhinovirus antigens." This invention involves an isolated peptide that comprises an amino acid sequence at least 90% identical to the VP4 amino acid sequence of a rhinovirus. Additionally, it includes an isolated polynucleotide encoding said peptide, which is placed under the control of elements necessary for its expression in a mammalian cell. The patent also covers a Th1 adjuvant when the immunogenic composition comprises one or more of the isolated peptides.
Career Highlights
Throughout his career, Walton Ross has worked with prominent organizations, including Sanofi Pasteur Inc. His experience in the pharmaceutical industry has allowed him to contribute to significant advancements in vaccine development and immunotherapy.
Collaborations
Walton has collaborated with esteemed colleagues such as Bruno Guy and Gary McLean. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of immunology.
Conclusion
Walton Ross is a distinguished inventor whose work in rhinovirus research has the potential to impact public health significantly. His innovative approaches and collaborations reflect his commitment to advancing medical science and improving patient outcomes.